Pathways and consequences: Hedgehog signaling in human disease

Trends in Cell Biology

Volumn 12, Issue 12, 2002, Pages 562-569

  Mullor, José L ^a   Sánchez, Pilar ^a   Ruiz i Altaba, Ariel ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLI PROTEIN; ONCOPROTEIN; SONIC HEDGEHOG PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; BONE; GENERAL ASPECTS OF DISEASE; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION; BONE DEFECT; BRAIN DEVELOPMENT; CANCER; DISEASE COURSE; FOREBRAIN; HEDGEHOG; MODEL; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSPORT VESICLE;

ANIMALS; BONE AND BONES; DISEASE; HEDGEHOG PROTEINS; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

ERINACEIDAE;

EID: 0036899614     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)02405-4     Document Type: Review

References (55)

1. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15:2001;3059-3087.
2. Ho K.S., Scott M.P. Sonic hedgehog in the nervous system: functions, modifications and mechanisms. Curr. Opin. Neurobiol. 12:2002;57-63.
3. Nybakken K., Perrimon N. Hedgehog signal transduction: recent findings. Curr. Opin. Genet. Dev. 12:2002;503-511.
4. Willnow T.E., et al. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8460-8464.
5. McCarthy R.A., et al. Megalin functions as an endocytic sonic hedgehog receptor. J. Biol. Chem. 277:2002;25660-25667.
6. Mao J., et al. Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem. 277:2002;35156-35161.
7. Aza-Blanc P., Kornberg T.B. Ci: a complex transducer of the hedgehog signal. Trends Genet. 15:1999;458-462.
8. Ruiz i Altaba A. The works of GLI and the power of hedgehog. Nat. Cell Biol. 1:1999;E147-E148.
9. Ruiz i Altaba A., et al. Hedgehog-Gli signalling and the growth of the brain. Nat. Rev. Neurosci. 3:2002;24-33.
10. Jessell T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 1:2000;20-29.
11. Ruiz i Altaba A., et al. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer. 2:2002;361-372.
12. Pathi S., et al. Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech. Dev. 106:2001;107-117.
13. Miao N., et al. Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult In vitro. J. Neurosci. 17:1997;5891-5899.
14. Traiffort E., et al. Discrete localizations of hedgehog signalling components in the developing and adult rat nervous system. Eur. J. Neurosci. 11:1999;3199-3214.
15. Dahmane N., et al. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development. 128:2001;5201-5212.
16. van den Brink G.R., et al. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology. 121:2001;317-328.
17. Cooper M.K., et al. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 280:1998;1603-1607.
18. Incardona J.P., et al. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development. 125:1998;3553-3562.
19. Roessler E., Muenke M. Midline and laterality defects: left and right meet in the middle. BioEssays. 23:2001;888-900.
20. Muenke M., Beachy P.A. Genetics of ventral forebrain development and holoprosencephaly. Curr. Opin. Genet. Dev. 10:2000;262-269.
21. Heussler H.S., et al. Extreme variability of expression of a Sonic Hedgehog mutation: attention difficulties and holoprosencephaly. Arch. Dis. Child. 86:2002;293-296.
22. Oro A.E., et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 276:1997;817-821.
23. Berman D.M., et al. Medulloblastoma growth inhibition by Hedgehog pathway blockade. Science. 297:2002;1559-1561.
24. Incardona J.P., Roelink H. The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly. Cell. Mol. Life Sci. 57:2000;1709-1719.
25. Bellaiche Y., et al. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature. 394:1998;85-88.
26. Lind T., et al. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J. Biol. Chem. 273:1998;26265-26268.
27. Simmons A.D., et al. A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses. Hum. Mol. Genet. 8:1999;2155-2164.
28. Taipale J., Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature. 411:2001;349-354.
29. Goodrich L.V., Scott M.P. Hedgehog and Patched in neural development and disease. Neuron. 21:1998;1243-1257.
30. Wetmore C., et al. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 61:2001;513-516.
31. Aszterbaum M., et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat. Med. 5:1999;1285-1291.
32. Ming J.E., et al. Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum. Genet. 110:2002;297-301.
33. Eggenschwiler J.T., et al. Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway. Nature. 412:2001;194-198.
34. Jeong J., McMahon A.P. Developmental biology. Vesicles and the spinal cord. Nature. 412:2001;136-137.
35. Stone A., et al. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J. Cell Sci. 112:1999;4437-4448.
36. Taylor M.D., et al. Mutations in SUFU predispose to medulloblastoma. Nat. Genet. 31:2002;306-310.
37. Litingtung Y., Chiang C. Specification of ventral neuron types is mediated by an antagonistic interaction between Shh and Gli3. Nat. Neurosci. 3:2000;979-985.
38. Erez A., et al. GLI3 is not mutated commonly in sporadic medulloblastomas. Cancer. 95:2002;28-31.
39. Dahmane N., et al. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature. 389:1997;876-881.
40. Nilsson M., et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3438-3443.
41. Grachtchouk M., et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet. 24:2000;216-217.
42. Park H.L., et al. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development. 127:2000;1593-1605.
43. Mo R., et al. Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development. 124:1997;113-123.
44. Brown S.A., et al. Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat. Genet. 20:1998;180-183.
45. Aruga J., et al. Zic2 controls cerebellar development in cooperation with Zic1. J. Neurosci. 22:2002;218-225.
46. Brewster R., et al. Gli/Zic factors pattern the neural plate by defining domains of cell differentiation. Nature. 393:1998;579-583.
47. Koyabu Y., et al. Physical and functional interactions between Zic and Gli proteins. J. Biol. Chem. 276:2001;6889-6892.
48. Kim P.C., et al. Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway. J. Pediatr. Surg. 36:2001;381-384.
49. Koike C., et al. Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431. Oncogene. 21:2002;2670-2678.
50. Sato N., et al. Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog. J. Clin. Invest. 104:1999;855-864.
51. Sato N., et al. Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia. J. Natl. Cancer Inst. 93:2001;1858-1864.
52. Tsuboi K., Shults C.W. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease. Exp. Neurol. 173:2002;95-104.
53. Pepinsky R.B., et al. Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model. J. Pharm. Sci. 91:2002;371-387.
54. Ahlgren S.C., et al. Sonic hedgehog rescues cranial neural crest from cell death induced by ethanol exposure. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10476-10481.
55. Taipale J., et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature. 406:2000;1005-1009.